Nonpharmacologic Analgesia for Invasive Procedures
Phase 2/Phase 3
18 Years
90 Years
18 Years
90 Years
Not Enrolling
Both
Pain, Anxiety
Both
Pain, Anxiety
Trial Information
Nonpharmacologic Analgesia for Invasive Procedures
Inclusion Criteria:
- Patients referred for transcatheter embolization for benign uterine fibroid tumors or
malignant hepatic tumors.
- Patients referred for radiofrequency ablation of malignant hepatic or renal tumors
Exclusion Criteria:
- Unable to give informed consent
- Impaired mental function, psychosis, severe chronic obstructive pulmonary disease,
intolerance towards midazolam or fentanyl
- Weigh < 55 kg
- Pregnant
- Unable to hear or understand English
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Principal Investigator
Elvira V. Lang, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Beth Israel Deaconess Medical Center
Authority:
United States: Federal Government
Study ID:
R01 AT000002
NCT ID:
NCT00010855
Start Date:
September 1997
Completion Date:
April 2007
Related Keywords:
- Pain
- Anxiety
- hypnosis
- relaxation
- invasive medical procedures
- interventional radiology
- conscious sedation
- anesthesia
- complications
- cost analysis
- Interventional procedures, complications
- Angiography
- Nephrostomy
- Hepatic chemoembolization
- Fibroid Embolization
- Anxiety Disorders
Name | Location |
|---|---|
| Beth Israel Deaconess Medical Center | Boston, Massachusetts 02215 |
